Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
IPR, Innovation, Human Rights and Access to Drugs - An Annotated Bibliography - Health Economics and Drugs Series No. 014
(2003; 82 pages) Ver el documento en el formato PDF
Documentos relacionados
Analysing globalization, patents and drugs now requires not only close attention to the public health consequences of the World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), but also an in depth study of the figures for the research and development (R&D) of new drugs. There is a need to establish what obligation, if any, international actors, such as private companies and national authorities, have in guaranteeing access to drugs. This bibliography brings together very different points of view from the most diverse quarters, ranging from academic experts to health professionals, including publications of pharmaceutical companies and nongovernmental organization (NGO) reports. Updating this bibliography, which was previously revised in 2001, constitutes clear evidence of the growing volume of literature (scientific, legal and other) being produced around the issue of access to drugs and globalization. A human rights perspective has been incorporated into this edition in order to enlarge the scope of arguments and opinions. This is necessary in order to better understand the inherent complexity of the issue and the role played by a wide range of factors and elements. The debate is far from closed but the sense of urgency and the need for a coherent response have prompted more constructive approaches. The discussion is no longer exclusively centred on the benefits or prejudices of the WTO TRIPS Agreement but rather focuses on the existing opportunities to adapt to ever-changing realities, particularly in developing countries where those in greatest need live. This edition has been enriched with over 60 new references. Basic literature on TRIPS, patents, R&D and human rights and access to drugs are to be found among the general articles. More focused works are referenced in the specific sections that have been included in this version or, in some cases, in the chapter pertaining to country studies by region. Indeed, the geographical division of previous editions is combined with a thematic approach, adding three new sections: TRIPS and patents, R&D and human rights and access to drugs. The aim of this new approach is to better capture the global nature of the issue while taking into consideration possible domestic implications and effects. New electronic addresses have been incorporated, reflecting the wider range of information sources on the subject that are now available, including newsletters, institutional web sites and other electronic initiatives.
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoAbbreviations and acronyms
Ver el documentoIntroduction
Ver el documento1. General articles
Abrir esta carpeta y ver su contenido2. Country studies by region
Abrir esta carpeta y ver su contenido3. TRIPS, drugs and human rights
Abrir esta carpeta y ver su contenido4. Electronic information
Ver el documentoOther documents in the EDM Health Economics and Drugs Series
Ver el documentoBack cover

IPR, Innovation, Human Rights and Access to Drugs - An Annotated Bibliography - Health Economics and Drugs Series No. 014


World Health Organization
Essential Drugs and Medicines Policy


Ir a la siguiente sección
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019